Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)
CUSIP: 87975F104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 34,382,284
- Total 13F shares
- 361,326
- Share change
- +278,421
- Total reported value
- $1,737,881
- Price per share
- $4.81
- Number of holders
- 24
- Value change
- +$1,328,649
- Number of buys
- 19
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 87975F104?
CUSIP 87975F104 identifies TELO - Telomir Pharmaceuticals, Inc. - Common Stock, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87975F104:
Top shareholders of TELO - Telomir Pharmaceuticals, Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Christopher Chapman MD |
3/4/5
|
CEO & Chairman, Director |
—
class O/S missing
|
975,610
|
$6,048,782 | — | 08 Feb 2024 | |
| Craig Eagle |
3/4/5
|
Director |
—
class O/S missing
|
487,805
|
$3,024,391 | — | 08 Feb 2024 | |
| Nathen Fuentes |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
101,134
|
$627,031 | — | 08 Feb 2024 | |
| Bradley Kroenig |
3/4/5
|
Director |
—
class O/S missing
|
48,781
|
$302,442 | — | 08 Feb 2024 | |
| Hugh Mccoll III |
3/4/5
|
Director |
—
class O/S missing
|
48,781
|
$302,442 | — | 08 Feb 2024 | |
| Talhia Tuck |
3/4/5
|
Director |
—
class O/S missing
|
48,781
|
$302,442 | — | 08 Feb 2024 | |
| Suncoast Equity Management |
13F
|
Company |
0.07%
|
24,391
|
$125,614 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
17,748
|
$92,822 | — | 31 Mar 2024 | |
| Lido Advisors, LLC |
13F
|
Company |
0.04%
|
15,000
|
$77,250 | — | 31 Mar 2024 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.04%
|
14,900
|
$77,000 | — | 31 Mar 2024 | |
| Beaird Harris Wealth Management, LLC |
13F
|
Company |
0.01%
|
4,673
|
$24,066 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,605
|
$13,624 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
600
|
$3,090 | — | 31 Mar 2024 |
Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) as of Q2 2024
As of 30 Jun 2024,
Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
361,326 shares.
The largest 10 holders included
BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, VANGUARD GROUP INC, Suncoast Equity Management, NEW YORK STATE COMMON RETIREMENT FUND, STATE STREET CORP, Beaird Harris Wealth Management, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and CITIGROUP INC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
7
Q2 2024 holders
24
Holder diff
17
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.